Thus, RIP shuttles between CD95/Fas death and FAK survival signaling to mediate anoikis. == INTRODUCTION == Although communication between cell death and survival signaling pathways is critical for the regulation of many cellular and NHS-Biotin tissue processes, the molecules that mediate this cross-talk have not been well NHS-Biotin explored. to mediate anoikis. == INTRODUCTION == Although communication between cell death Rabbit Polyclonal to SRPK3 and survival signaling pathways is critical for the regulation of many cellular and tissue processes, the molecules that mediate this cross-talk have not been well explored. Nuclear factor (NF)-B induces the expression of antiapoptotic proteins and inhibits cell death pathways (Wanget al., 1996,1998); however, other specific molecules that directly shuttle between cell death and survival processes have not been identified. We sought to explore this realm by examining the communication between the cell death receptors and integrin-mediated prosurvival signals. Death receptors such as tumor necrosis factor (TNF) receptor-1, DR3, DR4, DR5, and Fas/CD95 contain a cytoplasmic death domain and trigger apoptosis upon binding to their cognate ligands or specific agonistic antibodies. Activation of death receptors, such as Fas/CD95 leads to the formation of a death-inducing signaling complex (Krammer, 1999,2000). Cancer cells, including squamous cell carcinoma (SCC) cells, constitutively express death receptors, such as Fas, and undergo apoptosis in response to treatment with Fas ligand (FasL) or Fas agonistic antibody (Moerset al., 1999;Shibakitaet al., 1999). Signal transduction pathways for death receptors are well studied, and many signaling molecules are known to mediate death receptor-induced apoptosis (Peter and Krammer, 1998). However, the role of death receptors in extracellular matrix (ECM)-regulated anoikis, a form of apoptosis induced by loss of cellECM contacts, has not been explored. Focal adhesion kinase (FAK) is important in signal transduction pathways that regulate cell survival and thereby tumorigenesis. Its expression is enhanced in laryngeal SCC (Aronsohnet al., 2003) and invasive colon and breast tumors (Owenset al., 1995). Different FAK domains are involved in its binding to cell surface integrin receptors and in recruiting to focal adhesions other proteins that mediate survival signals. Phosphorylation of FAK mediates downstream signaling events that regulate survival (Schlaepferet al., 1994). Also, overexpression of constitutively active FAK rescues epithelial cell lines from anoikis (Frischet al., 1996), whereas inhibition of FAK by antisense techniques triggers apoptosis (Xuet al., 1996). Numerous studies have shown a protective role for FAK in apoptosis (Schaller, 2001). In addition, FasL and Fas are constitutively expressed in SCC, and SCC cells undergo apoptosis upon treatment with a FAS agonistic antibody (Moerset al., 1999;Shibakitaet al., 1999). Moreover, detachment of SCC cells from the ECM leads to suppression of FAK-mediated survival signaling, resulting in anoikis (Zhanget al., 2004). We hypothesize that anoikis in these cells is regulated by cross-talk between FAK survival pathways and death receptor-mediated cell death pathways. However, the mediators and the mechanisms of this cross-talk are not known. Receptor-interacting protein (RIP), a kinase that encodes a unique domain with homology to serine/threonine and tyrosine kinases, is constitutively expressed in many tissues (Stangeret al., 1995). RIP interacts with Fas/CD95 in yeast and cancer cell death pathways (Stangeret al., 1995). Through its interactions with the death NHS-Biotin receptors TNF receptor 1, TNF receptor-associated factor 2, and TNF receptor type 1-associated death domain protein, RIP plays a pivotal role in regulating NF-B (Meylan and Tschopp, 2005;Jackson-Bernitsaset al., 2007). RIP also interacts with the epidermal growth factor receptor and thereby contributes to activation of NF-B by epidermal growth factor (Habibet al., 2001). In cell models, RIP is critical in NF-B activation induced by the death receptor TNF-related apoptosis-inducing ligand (TRAIL) and by DNA-damaging agents (Linet al., 2000;Meylan and Tschopp, 2005). RIP also contributes to TNF-induced activation of c-Jun NH2-terminal kinase and extracellular signal-related kinase (ERK) (Devinet al., 2003). Furthermore, RIP interacts with FAK to suppress apoptosis and contributes to TNF-mediated activation of NF-B (Kurenovaet al., 2004). In NHS-Biotin vivo, RIP plays a role in apoptosis as supported by the findings in RIP null mice (Kelliheret al., 1998). Thus, RIP seems to participate in both cell survival and cell death pathways (Meylan and Tschopp, 2005); however, its ability to interplay between cell death receptor pathways and survival pathways has not been explored. Previously, we showed that an altered fibronectin matrix (Kapilaet al., 1997) induces anoikis of human SCC cells by suppressing integrin v-mediated phosphorylation of FAK and ERK (Kamarajan and Kapila, 2007). In this study, we examined the link between the death receptor and survival integrin/FAK signaling pathways in regulating anoikis. Identification of key signaling mediators in this process could be useful in identifying therapeutic targets for the treatment of SCC. == MATERIALS AND METHODS == == Cell Lines and Culture == The highly invasive human oral SCC cell line HSC-3 (Owenset al., NHS-Biotin 1995) was kindly provided by Randy Kramer (University of California, San Francisco, San Francisco, CA). The human SCC cell line UM-SCC1 was a gift from Tom Carey (University of Michigan, Ann Arbor, MI). RIP+/+and RIP/mouse embryonic fibroblasts (MEFs) were kindly provided by Philip Leder and Michelle Kelliher (Harvard Medical School,.